Monocytes exposed to LPS and IL-15 expressed significantly higher levels of IL-6 and monocyte chemoattractant protein-1 (MCP-1) in DN patients compared to healthy controls and DM2 patients (both p < 0.01) [33]. This evidence concerns the gene IL15 and myotonic dystrophy type 2.